Gabapentin Capsule
Product Images NDC 70518-2614

15 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70518-2614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

Gabapentin-equation (Gabapentin Equation)
This image shows a mathematical formula used to calculate creatinine clearance (CLCr), involving factors such as age, weight, serum creatinine levels, and an adjustment multiplier for female patients. It appears on a drug information panel likely related to pharmacokinetics or dosing considerations.*
FDA Label Image

Structure (Gabapentin Fig 5)

Structure (Gabapentin Fig 5)
Chemical structure of the active ingredient gabapentin, showing a cyclohexane ring attached to an amino group (CH2NH2) and a carboxylic acid group (CH2CO2H).*
FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
A line graph showing mean pain scores over eight weeks comparing placebo and Gabapentin, 3600 mg/day. The x-axis represents weeks including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing trend in pain scores, whereas placebo remains relatively stable.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Gabapentin-fig2 (Gabapentin Fig2)
A line graph depicting mean pain scores over a 7-week period for three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, and the y-axis shows mean pain score ranging from 0 to 10. The graph highlights a 3-week dose titration period followed by a 4-week fixed dose period, with gabapentin groups showing lower pain scores compared to placebo over time.*
FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

Gabapentin-fig3 (Gabapentin Fig3)
A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) groups in two separate studies. Study 1 shows 12% response for placebo and 29% for gabapentin 3600 mg. Study 2 shows 14% response for placebo, 32% for gabapentin 1800 mg, and 34% for gabapentin 2400 mg, with statistical significance indicated.*
FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

Gabapentin-fig4.jpg (Gabapentin Fig4)
A scatter plot chart showing the relationship between daily dose (mg) on the x-axis ranging approximately from 600 to 1800 mg, and difference (%) on the y-axis ranging from 2% to 22%. The data points represent three studies labeled as STUDY a (black squares), STUDY b (gray squares), and STUDY c (white squares). Each study shows data points at different daily doses with corresponding percentage differences.*
FDA Label Image

Mm1 (Gabapentin 100mg 70518 2614 00)

Mm1 (Gabapentin 100mg 70518 2614 00)
Gabapentin Capsule 100 mg in a carton labeling containing 90 capsules. The label includes the NDC 70518-2614-00 and indicates the capsules are white size 218. It is repackaged by RemedyRepack Inc., Indiana, PA, with contact phone number 724.465.8762. Storage instructions and manufacturer details (Ascend Labs, LLC) are also shown.*
FDA Label Image

Mm2 (Gabapentin 100mg 70518 2614 01)

Mm2 (Gabapentin 100mg 70518 2614 01)
Gabapentin 100 mg capsule label showing quantity of 270 capsules. The label includes the NDC number 70518-2614-01, indicates the capsules are white, and states the product is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and manufacturer information for Ascend Labs, LLC, are also partially visible.*
FDA Label Image

Mm3 (Gabapentin 100mg 70518 2614 02)

Mm3 (Gabapentin 100mg 70518 2614 02)
Gabapentin Capsule 100 mg in oral capsule form, packaged by RemedyRepack Inc. The label shows a quantity of 30 capsules, NDC number 70518-2614-02, with a white capsule size 218. The label includes storage instructions and a manufacturer MFG NDC 67877-0222-10 from Ascend Labs, LLC.*
FDA Label Image

Mm4 (Gabapentin 100mg 70518 2614 03)

Mm4 (Gabapentin 100mg 70518 2614 03)
Gabapentin Capsule 100 mg oral capsules packaging label showing a quantity of 30 capsules. Label includes NDC 70518-2614-03 and indicates the capsules are white, size 218. It is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and manufacturer details for Ascend Labs, LLC are also present.*
FDA Label Image

Mm5 (Gabapentin 100mg 70518 2614 04)

Mm5 (Gabapentin 100mg 70518 2614 04)
Gabapentin 100 mg oral capsules packaging label showing 100 capsules per box. Labeled by RemedyRepack Inc., Indiana, PA. The label includes storage instructions and mentions repackaging by RemedyRepack. The original manufacturer is Ascend Labs, LLC.*
FDA Label Image

Mm6 (Gabapentin 100mg 70518 2614 05)

Mm6 (Gabapentin 100mg 70518 2614 05)
Label for Gabapentin Capsule 100 mg oral dosage form, quantity of 1 capsule. The label includes the NDC number 70518-2614-05, and indicates the capsule color as white. It is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and a QR code are also visible on the label.*
FDA Label Image

Mm7 (Gabapentin 100mg 70518 2614 06)

Mm7 (Gabapentin 100mg 70518 2614 06)
Label for Gabapentin Capsule 100 mg in a 60-count package, labeled by Remedy Repack Inc. The label indicates oral capsule dosage form, includes NDC 70518-2614-06, and states storage and handling instructions. The manufacturing NDC and manufacturer information for Ascend Labs, LLC are also shown.*
FDA Label Image

Mm8 (Gabapentin 100mg 70518 2614 07)

Mm8 (Gabapentin 100mg 70518 2614 07)
Gabapentin 100 mg oral capsules packaging label showing a quantity of 100 capsules. The label indicates it is repackaged by Remedy Repack Inc. The original manufacturer is Ascend Labs, LLC, Montvale, NJ. The NDC number is 70518-2614-07, with storage instructions and a QR code present on the label.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Gabapentin 100 mg capsules label showing a quantity of 90. The label includes the NDC number 70518-2614-00 and states the product is repackaged by RemedyRepack Inc. The manufacturer listed is Ascend Labs, LLC, Montvale, NJ. Directions advise to see the package insert and storage instructions are provided. The label indicates the product is for Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.